Published in J Immunol on June 01, 1981
Diagnosis of chronic myeloid and acute lymphocytic leukemias by detection of leukemia-specific mRNA sequences amplified in vitro. Proc Natl Acad Sci U S A (1988) 4.40
The BCR-ABL oncogene transforms Rat-1 cells and cooperates with v-myc. Mol Cell Biol (1989) 2.87
Overlapping cDNA clones define the complete coding region for the P210c-abl gene product associated with chronic myelogenous leukemia cells containing the Philadelphia chromosome. Proc Natl Acad Sci U S A (1986) 1.97
Synergism of v-myc and v-Ha-ras in the in vitro neoplastic progression of murine lymphoid cells. Mol Cell Biol (1986) 1.42
C/EBP-related protein 2 confers lipopolysaccharide-inducible expression of interleukin 6 and monocyte chemoattractant protein 1 to a lymphoblastic cell line. Proc Natl Acad Sci U S A (1994) 1.04
The role of I-J and Igh determinants on F1-derived suppressor factor in controlling restriction specificity. J Exp Med (1983) 0.83
Variable expression of the translocated c-abl oncogene in Philadelphia-chromosome-positive B-lymphoid cell lines from chronic myelogenous leukemia patients. Proc Natl Acad Sci U S A (1986) 0.80
Induction of murine CD5 expression by v-H-ras. Immunology (1997) 0.75
DNA-dependent transcription of adenovirus genes in a soluble whole-cell extract. Proc Natl Acad Sci U S A (1980) 24.21
Analysis of DNA polymerases II and 3 in mutants of Escherichia coli thermosensitive for DNA synthesis. Proc Natl Acad Sci U S A (1971) 7.94
Properties and applications of monoclonal antibodies directed against determinants of they Thy-1 locus. J Immunol (1979) 7.79
Cell-cycle control of c-myc but not c-ras expression is lost following chemical transformation. Cell (1984) 6.53
A DNA-unwinding protein isolated from Escherichia coli: its interaction with DNA and with DNA polymerases. Proc Natl Acad Sci U S A (1972) 5.83
A simple method for polyethylene glycol-promoted hybridization of mouse myeloma cells. Somatic Cell Genet (1977) 5.65
Structure and in vitro transcription of human globin genes. Science (1980) 4.65
Duplicate genes for tyrosine transfer RNA in Escherichia coli. J Mol Biol (1970) 4.36
Role modifications in tyrosine transfer RNA: a modified base affecting ribosome binding. J Mol Biol (1969) 4.01
Aberrant nuclear factor-kappaB/Rel expression and the pathogenesis of breast cancer. J Clin Invest (1997) 3.96
Purification and DNA synthesis in cell-free extracts: properties of DNA polymerase II. Proc Natl Acad Sci U S A (1971) 3.95
RNA synthesis in isolated nuclei: in vitro initiation of adenovirus 2 major late mRNA precursor. Proc Natl Acad Sci U S A (1979) 3.75
The enzymatic repair of DNA. I. Formation of circular lambda-DNA. Proc Natl Acad Sci U S A (1967) 3.67
Efficacy of a therapeutic cocaine vaccine in rodent models. Nat Med (1996) 3.11
Perinatal lethal osteogenesis imperfecta (OI type II): a biochemically heterogeneous disorder usually due to new mutations in the genes for type I collagen. Am J Hum Genet (1988) 3.00
RNA synthesis in isolated nuclei: identification and comparison of adenovirus 2 encoded transcripts synthesized in vitro and vivo. J Mol Biol (1979) 2.86
Bacteriophage phi 80-induced low molecular weight RNA. Arch Biochem Biophys (1972) 2.71
Inhibition of NF-kappaB/Rel induces apoptosis of murine B cells. EMBO J (1996) 2.68
Immunological self, nonself discrimination. Science (1987) 2.59
Base substitution in an intervening sequence of a beta+-thalassemic human globin gene. Proc Natl Acad Sci U S A (1981) 2.58
The genetic basis of antibody production: a single heavy chain variable region gene encodes all molecules bearing the dominant anti-arsonate idiotype in the strain A mouse. Eur J Immunol (1983) 2.51
Saccharomyces cerevisiae tRNA ligase. Purification of the protein and isolation of the structural gene. J Biol Chem (1986) 2.42
Deoxyribonucleic acid synthesis in cell-free extracts. IV. Purification and catalytic properties of deoxyribonucleic acid polymerase III. J Biol Chem (1972) 2.36
Interaction of peptide antigens and class II major histocompatibility complex antigens. Nature (1987) 2.34
Lateral diffusion of membrane-spanning and glycosylphosphatidylinositol-linked proteins: toward establishing rules governing the lateral mobility of membrane proteins. J Cell Biol (1991) 2.28
Somatic evolution of variable region structures during an immune response. Proc Natl Acad Sci U S A (1986) 2.23
Purification and properties of the Escherichia coli deoxyribonucleic acid-unwinding protein. Effects on deoxyribonucleic acid synthesis in vitro. J Biol Chem (1974) 2.22
DNA replication. Annu Rev Biochem (1975) 2.18
Enzyme-catalyzed DNA unwinding: studies on Escherichia coli rep protein. Proc Natl Acad Sci U S A (1979) 2.14
Interaction of an NF-kappa B-like factor with a site upstream of the c-myc promoter. Proc Natl Acad Sci U S A (1990) 2.06
Repression of transcription of the p27(Kip1) cyclin-dependent kinase inhibitor gene by c-Myc. Oncogene (2001) 2.05
Dual expression of lambda genes in the MOPC-315 plasmacytoma. Nature (1981) 2.03
Regulation of c-myc transcription and mRNA abundance by serum growth factors and cell contact. J Biol Chem (1986) 2.00
Hybridoma proteins expressing the predominant idiotype of the antiazophenylarsonate response of A/J mice. Proc Natl Acad Sci U S A (1980) 1.96
DNA synthesis in cell-free extracts of a DNA polymerase-defective mutant. Biochem Biophys Res Commun (1970) 1.91
Protein kinase CK2 in mammary gland tumorigenesis. Oncogene (2001) 1.90
Mutational analysis of the immunoglobulin heavy chain promoter region. Proc Natl Acad Sci U S A (1986) 1.89
Isolation of a murine Ly-6 cDNA reveals a new multigene family. EMBO J (1986) 1.88
Interactions between immunogenic peptides and MHC proteins. Annu Rev Immunol (1991) 1.82
TGF beta 1 inhibits NF-kappa B/Rel activity inducing apoptosis of B cells: transcriptional activation of I kappa B alpha. Immunity (1996) 1.81
Evolution of antibody variable region structure during the immune response. Immunol Rev (1987) 1.77
Specific regulation of c-myc oncogene expression in a murine B-cell lymphoma. Proc Natl Acad Sci U S A (1984) 1.76
Monoclonal antibodies to Rhizobium meliloti and surface mutants insensitive to them. J Bacteriol (1984) 1.70
Characterization of the gamma-interferon-mediated induction of antigen-presenting ability in P388D1 cells. J Immunol (1983) 1.69
Differential regulation of the c-myc oncogene promoter by the NF-kappa B rel family of transcription factors. Mol Cell Biol (1994) 1.68
Affinity analysis of idiotype-positive and idiotype-negative Ars-binding hybridoma proteins and Ars-immune sera. Mol Immunol (1983) 1.67
The RelA NF-kappaB subunit and the aryl hydrocarbon receptor (AhR) cooperate to transactivate the c-myc promoter in mammary cells. Oncogene (2000) 1.66
Characterization of a fused protein specified by the adenovirus type 2-simian virus 40 hybrid Ad2+ND1 dp2. J Virol (1979) 1.65
An iron-dependent modification of several transfer RNA species in Escherichia coli. J Mol Biol (1969) 1.63
The genetic basis of antibody production: the dominant anti-arsonate idiotype response of the strain A mouse. Eur J Immunol (1982) 1.60
Her-2/neu overexpression induces NF-kappaB via a PI3-kinase/Akt pathway involving calpain-mediated degradation of IkappaB-alpha that can be inhibited by the tumor suppressor PTEN. Oncogene (2001) 1.59
The T-cell-independent immune response to the hapten NP uses a large repertoire of heavy chain genes. Cell (1985) 1.59
Independent regulation of transcription of the two strands of the c-myc gene. Mol Cell Biol (1987) 1.58
Influence of clonal selection on the expression of immunoglobulin variable region genes. Science (1984) 1.57
Transactivation of the c-myc promoter by human T cell leukemia virus type 1 tax is mediated by NF kappa B. J Biol Chem (1992) 1.56
Properties of the Escherichia coli in DNA binding (unwinding) protein: interaction with DNA polymerase and DNA. Proc Natl Acad Sci U S A (1974) 1.54
Expression and rearrangement of homologous immunoglobulin VH genes in two mouse strains. Proc Natl Acad Sci U S A (1984) 1.54
A limited number of B cell lineages generates the heterogeneity of a secondary immune response. J Immunol (1987) 1.53
Transcriptional activation of immunoglobulin alpha heavy-chain genes by translocation of the c-myc oncogene. Nature (1983) 1.51
Protein kinase CK2 in health and disease: CK2 and its role in Wnt and NF-kappaB signaling: linking development and cancer. Cell Mol Life Sci (2009) 1.50
Physical linkage of the constant region genes for immunoglobulins lambda I and lambda III. Proc Natl Acad Sci U S A (1981) 1.50
Roles of IKK kinases and protein kinase CK2 in activation of nuclear factor-kappaB in breast cancer. Cancer Res (2001) 1.43
Elevated expression of monocyte chemoattractant protein 1 by vascular smooth muscle cells in hypercholesterolemic primates. Proc Natl Acad Sci U S A (1992) 1.42
Synergism of v-myc and v-Ha-ras in the in vitro neoplastic progression of murine lymphoid cells. Mol Cell Biol (1986) 1.42
Properties of the Escherichia coli DNA-binding (unwinding) protein interaction with nucleolytic enzymes and DNA. J Mol Biol (1975) 1.42
Effect of IFN-gamma on the immune response in vivo and on gene expression in vitro. Nature (1984) 1.41
Tumor necrosis factor alpha transcription in macrophages is attenuated by an autocrine factor that preferentially induces NF-kappaB p50. Mol Cell Biol (1998) 1.41
Enzymatic mechanism of an RNA ligase from wheat germ. J Biol Chem (1983) 1.39
A DNA-binding protein induced by bacteriophage T7. Proc Natl Acad Sci U S A (1973) 1.39
Intracellular association of the protein product of the c-myc oncogene with the TATA-binding protein. Mol Cell Biol (1994) 1.39
Activation of NF-kappaB/Rel occurs early during neoplastic transformation of mammary cells. Carcinogenesis (2000) 1.38
Nuclear factor-kappaB/Rel blocks transforming growth factor beta1-induced apoptosis of murine hepatocyte cell lines. Cell Growth Differ (1997) 1.36
Expression of a constitutive NF-kappa B-like activity is essential for proliferation of cultured bovine vascular smooth muscle cells. J Clin Invest (1995) 1.36
Mutant tyrosine transfer ribonucleic acids. J Mol Biol (1970) 1.36
Immunological activity of covalently linked T-cell epitopes. Nature (1990) 1.35
Role of Rel-related factors in control of c-myc gene transcription in receptor-mediated apoptosis of the murine B cell WEHI 231 line. J Exp Med (1995) 1.35
Murine MHC polymorphism and T cell specificities. Science (1989) 1.34
Site-directed mutagenesis of an invariant amino acid residue at the variable-diversity segments junction of an antibody. Proc Natl Acad Sci U S A (1986) 1.32
Transcriptional and posttranscriptional control of c-myc gene expression in WEHI 231 cells. Mol Cell Biol (1986) 1.32
Isolation of hybridomas expressing a specific heavy chain variable region gene segment by using a screening technique that detects mRNA sequences in whole cell lysates. Proc Natl Acad Sci U S A (1984) 1.30
Structural diversity among anti-p-azophenylarsonate monoclonal antibodies from A/J mice; comparison of Id- and Id+ sequences. Mol Immunol (1981) 1.29
Synthesis of messenger RNA-like molecules in isolated myeloma nuclei. Nucleic Acids Res (1977) 1.29
Use of molecular haplotypes specific for the human pro alpha 2(I) collagen gene in linkage analysis of the mild autosomal dominant forms of osteogenesis imperfecta. Am J Hum Genet (1986) 1.29
Regulation of immunoglobulin expression in mouse myeloma cells. Cold Spring Harb Symp Quant Biol (1977) 1.28
Delta 2 -isopentenylpyrophosphate: transfer ribonucleic acid 2 -isopentenyltransferase from Escherichia coli. Purification and properties of the enzyme. J Biol Chem (1972) 1.28
Restricted V-(D)-J junctional regions in the T cell response to lambda-repressor. Identification of residues critical for antigen recognition. J Immunol (1990) 1.28
The C/EBP bZIP domain can mediate lipopolysaccharide induction of the proinflammatory cytokines interleukin-6 and monocyte chemoattractant protein-1. J Biol Chem (2000) 1.26
T lymphocyte response to bacteriophage lambda repressor cI protein. Recognition of the same peptide presented by Ia molecules of different haplotypes. J Immunol (1987) 1.23
Deoxyribonucleic acid synthesis in cell-free extracts. 3. Catalytic properties of deoxyribonucleic acid polymerase II. J Biol Chem (1972) 1.23
Regulation of oncogene expression in cultured aortic smooth muscle cells. Post-transcriptional control of c-myc mRNA. J Biol Chem (1986) 1.23
Redundancy of C/EBP alpha, -beta, and -delta in supporting the lipopolysaccharide-induced transcription of IL-6 and monocyte chemoattractant protein-1. J Immunol (1998) 1.23
In vitro synthesis of transfer RNA. II. Identification of required enzymatic activities. J Biol Chem (1975) 1.22
Transcription of immunoglobulin heavy-chain sequences from the excluded allele. Nature (1981) 1.21
Role of the IkappaB kinase complex in oncogenic Ras- and Raf-mediated transformation of rat liver epithelial cells. Mol Cell Biol (2000) 1.21
Recurrent somatic mutations in mouse antibodies to p-azophenylarsonate increase affinity for hapten. J Immunol (1989) 1.21
Murine Ly-6 multigene family is located on chromosome 15. Proc Natl Acad Sci U S A (1987) 1.20